Catalyst Wire Dossier Catalyst Wire Dossier

KLAYESTA

Nystatin topical powder · Epic Pharma, LLC
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for KLAYESTA, covering 2018-04-30 to 2018-04-30. Get the full timeline:

Most recent: FDA Approved: KLAYESTA — Original Application (Epic Pharma, LLC)

See pricing